Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

NCT00977665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy

Interventions

DRUG: rasagiline mesylate
DRUG: placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]